ROCKVILLE, Md., Nov 08, 2010 (BUSINESS WIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the following investor conferences during the months of November and December 2010.
- The Lazard Capital Markets 7th Annual Healthcare Conference 2010
New York, NY.
November 17, 2010
Presentation Time: 1:45 PM Eastern
- The J.P. Morgan SMid Cap Conference 2010
New York, NY.
December 2, 2010
Presentation Time: 2:15 PM Eastern
During each presentation, a member of the company's senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities and financial performance.
A webcast of these presentations will be available both live and by replay, accessible from the company's website www.emergentbiosolutions.com under "Investors".
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information may be found at www.emergentbiosolutions.com.
SOURCE: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Robert G. Burrows
Vice President, Investor Relations
Director, Corporate Communications